About US
Contact us
-
Chimerix, ContraVir collaborate to develop and commercialize antiviral drug candidate CMX157Chimerix, Inc. (NASDAQ: CMRX) a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, and ContraVir Pharmaceuticals, Inc. (OTCBB: CTRV), a biopharmaceutical2014/12/19
-
High-dose flu vaccine better than regular flu shot for frail, older adults of long-term care facilitiesThe high-dose flu vaccine is significantly better than the regular flu shot at boosting the immune response to the flu virus in frail, older residents of long-term care facilities, according to the re2014/12/18
-
Pfizer and OPKO collaborate to develop and commercialise hGH-CTP to treat GHDUS-based drug maker Pfizer has signed a worldwide agreement with OPKO Health to develop and commercialise hGH-CTP to treat growth hormone deficiency (GHD) in adults and children. The agreement includ2014/12/18
-
GlaxoSmithKline Manufacturing Facility Expansion, Boronia, AustraliaGlaxoSmithKline (GSK) announced the expansion of its manufacturing facility in Boronia, in the outer eastern suburbs of Melbourne, Australia, in November 2014. The expansion will introduce the latest2014/12/17
-
Nanotherapeutics to acquire Baxter’s Vero cell vaccines platformBaxter International has signed an agreement with Nanotherapeutics to sell its Vero cell technology and related assets. The agreement includes its production facility in Bohumil, Czech Republic. The2014/12/17
-
Janssen and USAID collaborate to expand access to MDR-TB compoundJohnson & Johnson associate Janssen Therapeutics has signed a memorandum of understanding (MoU) with US Agency for International Development (USAID) to expand access to anti-multidrug-resistant tu2014/12/16
-
New Zealand approves Mylan-Abbott $5bn dealNew Zealand's competition watchdog Commerce Commission has approved Mylan's purchase of Abbott Laboratories's generic medicines arm Established Pharmaceuticals. The commission's clearance is limited2014/12/16
-
Sanofi receives FDA approval for Fluzone Intradermal Quadrivalent vaccine to treat influenzaSanofi Pasteur has received approval from US Food and Drug Administration (FDA) for its Fluzone Intradermal Quadrivalent vaccine. The vaccine will provide protection against four strains of influenza2014/12/16
-
UK reserves ready for Sierra Leone deployment to fight against EbolaThe UK reserves and approximately 100 regulars are set to be deployed to Sierra Leone to help fight the Ebola outbreak. Regular and reserve personnel from across three services are currently undergoi2014/12/15
-
Germany bans 80 generic drugs trialled at GVK Biosciences facility in IndiaGermany has banned 80 generic drugs that had clinical trials performed by GVK Biosciences in India and found to be substandard. The ban by Germany's Federal Institute for Drugs and Medical Devices (B2014/12/15